BMY | Antibody Drugs Market to Witness Huge Growth by 2026 : Johnson & Johnson, Novartis, Bristol-Myers Squibb

Edison, NJ — ( SBWIRE ) — 10/27/2020 — Global Antibody Drugs Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread) is latest research study released by HTF MI evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making […]

BMY | Sensyne signs research deal with Milton Keynes University Hospital for ethical application of clinic

Sensyne Health PLC (LON:SENS) said it has signed a non-exclusive strategic research agreement (SRA) with Milton Keynes University Hospital NHS Foundation Trust (MKUH) to enable the ethical application of clinical artificial intelligence (AI) research to improve patient care and research into new medicines.The AIM-listed firm said the five-year deal will see a dataset covering 650,000 […]

BMY | Analysts Expect Bristol-Myers Squibb (NYSE:BMY) to Post $1.49 EPS

Wall Street brokerages expect Bristol-Myers Squibb (NYSE:BMY) to post $1.49 earnings per share for the current fiscal quarter, according to Zacks.Three analysts have issued estimates for Bristol-Myers Squibb’s earnings, with the lowest EPS estimate coming in at $1.44 and the highest estimate coming in at $1.53.Bristol-Myers Squibb posted earnings per share of $1.17 […]US Banking […]

BMY | Bristol-Myers Squibb (NYSE:BMY) Now Covered by Analysts at Truist

Truist began coverage on shares of Bristol-Myers Squibb (NYSE:BMY) in a report issued on Friday, The Fly reports.The brokerage issued a hold rating and a $65.00 price target on the biopharmaceutical company’s stock.Other equities analysts have also recently issued research reports about the company.Morgan Stanley upped their price target on Bristol-Myers Squibb […]Stock Observer

BMY | Gilead is set to sell billions of dollars of a coronavirus drug that’s far from ‘amazing’ after the US approved remdesivir to treat COVID-19

Summary List Placement The first approval of a COVID-19 drug in the US wasn’t quite a cause for celebration.US regulators approved the virus-fighting drug remdesivir on Thursday, greenlighting its use in hospitalized patients.The US Food and Drug Administration had given an emergency OK for the drug’s use in May.But it’s unclear how well remdesivir, marketed […]